Proton therapy with a fixed beamline for skull-base chordomas and chondrosarcomas: outcomes and toxicity.

Treatment with a fixed proton beam shows promising disease control and an acceptable toxicity rate, even the difficult-to-treat subpopulation of patients with skull-base chordomas or chondrosarcomas requiring dose escalation.